Neuralink plans to conduct the first human implants of its Blindsight device within the next 6 to 12 months. The timeline depends on receiving necessary regulatory approvals. The technology aims to restore visual perception by directly stimulating the visual cortex, bypassing traditional camera and cable systems.
The device is intended for individuals who cannot benefit from standard retinal or optic-nerve treatments. Elon Musk described the initial image resolution as comparable to early video game graphics, though long-term research goals suggest the potential for output that could eventually exceed natural human vision.
The company previously tested similar implants in monkeys, with one subject carrying the device for three years as of mid-2025. By January 28, 2026, Neuralink had successfully placed its N1 motor-control implant in 21 participants worldwide. Unlike the N1, which reads brain signals, Blindsight is designed to write information into the brain.
